Format

Send to

Choose Destination
See comment in PubMed Commons below
Nanomedicine. 2008 Jun;4(2):127-38. doi: 10.1016/j.nano.2008.03.001. Epub 2008 May 2.

Medical nanorobotics for diabetes control.

Author information

1
CAN Center for Automation in Nanobiotech, Melbourne VIC, Australia. adrianocavalcanti@canbiotechnems.com

Abstract

This work presents an innovative nanorobot architecture based on nanobioelectronics for diabetes. The progressive development toward the therapeutic use of nanorobots should be observed as the natural result from some ongoing and future achievements in biomedical instrumentation, wireless communication, remote power transmission, nanoelectronics, new materials engineering, chemistry, proteomics, and photonics. To illustrate the nanorobot integrated circuit architecture and layout described here, a computational approach with the application of medical nanorobotics for diabetes is simulated using clinical data. Integrated simulation can provide interactive tools for addressing nanorobot choices on sensing, hardware design specification, manufacturing analysis, and methodology for control investigation. In the proposed 3D prototyping, a physician can help the patient to avoid hyperglycemia by means of a handheld device, like a cell phone enclosed with cloth, that is used as a smart portable device to communicate with nanorobots. Therefore, this architecture provides a suitable choice to establish a practical medical nanorobotics platform for in vivo health monitoring.

PMID:
18455965
DOI:
10.1016/j.nano.2008.03.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center